Essent Group Ltd.
NYSE:ESNTInsurance - Specialty
+$0.17 today
- Market cap
- $5.66B
- Beta
- 0.78
- P/E (TTM)
- 8.1
- EPS (TTM)
- $7.32
- Dividend yield
- 2.23%
Volume 0.60M
Average 0.72M
ESNT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Essent Group Ltd.NYSE: ESNT
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ESNT compares with its peers on the latest reported figures
- ESNT's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for ESNT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ESNT) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for ESNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.03B | 1.02B | 1.13B | 1.27B | 1.26B |
| Cost of Revenue | 31.06M | (174.7M) | 31.54M | 81.22M | 149.34M |
| Gross Profit | 997.45M | 1.19B | 1.1B | 1.19B | 1.11B |
| Gross Margin | 97.0% | 117.2% | 97.2% | 93.6% | 88.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 101.34M | 100.3M | 114.9M | 136.39M | 0 |
| Operating Expenses | 175.14M | 204.86M | 276.54M | 330.44M | 289.74M |
| Depreciation & Amortization | 3.38M | 3.02M | 4.53M | 5.78M | 5.23M |
| EBITDA | 833.98M | 1.01B | 857.66M | 896.59M | 859.79M |
| EBITDA Margin | 81.1% | 98.9% | 75.8% | 70.8% | 68.2% |
| Operating Income | 822.31M | 988.19M | 823M | 855.49M | 821.86M |
| Operating Margin | 80.0% | 97.0% | 72.8% | 67.5% | 65.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 8.28M | 15.61M | 30.14M | 35.32M | 32.7M |
| Other Income / Expenses | 0 | (2K) | 0 | 0 | 0 |
| Income Before Tax | 822.31M | 988.19M | 823M | 855.49M | 821.86M |
| Pre-Tax Margin | 80.0% | 97.0% | 72.8% | 67.5% | 65.2% |
| Income Tax Expense | 140.53M | 156.83M | 126.61M | 126.09M | 131.89M |
| Net Income | 681.78M | 831.35M | 696.39M | 729.4M | 689.97M |
| Net Margin | 66.3% | 81.6% | 61.6% | 57.6% | 54.7% |
| EPS (Basic) | 6.13 | 7.75 | 6.56 | 6.92 | 6.97 |
| EPS (Diluted) | 6.11 | 7.72 | 6.50 | 6.85 | 6.90 |
| Weighted Avg Shares | 111.16M | 107.21M | 106.22M | 105.39M | 99M |
| Weighted Avg Shares (Diluted) | 111.56M | 107.65M | 107.13M | 106.55M | 100.02M |
Essent Group Ltd.
NYSE:ESNT
Intrinsic Alpha fair value
Locked
Current Price
$64.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.